pubrio
Peptron logo
기타Founded 1997🇰🇷 대한민국

SmartDepotTM is Peptron’s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner. SmartDepotTM is a next generation technology featuring various release profiles from 1 week to 6 months, showing high production yield and enabling mass production, differentiated from existing SR technology. SmartDepotTM is highly applicable to various peptide and small molecule drug. Patented technology ensures manufacturing and quality aspects of the competitive product development. Peptron has been developing anti-diabetes drug, anti-neurodegenerative disease drug, anti-acromegaly drug, anti-schizophrenia drug, which will be marketed in collaboration with global partners.

설립
1997
산업
기타
주식
koe: 087010.KQ
본사
🇰🇷37-24, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, Korea, Republic Of, 34054
전문 분야
기타

확장 인텔리전스

NEW · Pubrio 단독

Peptron의 시장 확장을 추적하고 있습니다

글로벌 확장

실시간
단계
탐색 중투자 중진입 중운영 중

활동 펄스

최근 90일간 시그널 1건.

최근 90일
채용
0
활동 없음
마케팅 및 PR
0
활동 없음
제품 및 기술
0
활동 없음
+2개 카테고리 더잠김
5개 중 3개 표시
알아두면 좋은 정보

Peptron 관련 자주 묻는 질문

Peptron의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.

SmartDepotTM is Peptron’s proprietary ultrasonic spray drying technology for the preparation of sustained release (SR) injectable microsphere formulation of drug. Recently, this long-acting technology has attracted the intense attention of global pharmaceutical companies since the costs for developing new medicines are soaring and patent expirations of many blockbuster drugs are just around the corner. SmartDepotTM is a next generation technology featuring various release profiles from 1 week to 6 months, showing high production yield and enabling mass production, differentiated from existing SR technology. SmartDepotTM is highly applicable to various peptide and small molecule drug. Patented technology ensures manufacturing and quality aspects of the competitive product development. Peptron has been developing anti-diabetes drug, anti-neurodegenerative disease drug, anti-acromegaly drug, anti-schizophrenia drug, which will be marketed in collaboration with global partners.

오늘 바로 여정을 시작하세요

플랫폼부터 시작해도, 대화부터 시작해도 좋습니다

직접 Pubrio 를 사용하거나, 연구·리드 생성·데이터 통합을 저희 팀에 맡겨 보세요.

팀과 상담하기
Start Journey Image
pubrio

Pubrio는 50개 이상의 로컬 소스에서 비즈니스·인물·의도 데이터를 통합해 하나의 글로벌 그래프로 제공, 시장 전체 가시성을 확보하게 합니다.

© 2026 Pubrio. 모든 권리 보유.